Nootropics Marke size was valued at USD 2.1 billion in 2021, growing at a CAGR of 12.5% from 2022-28. Growing prevalence of depression and mental exhaustion among youth has projected global nootropic products market growth. As well as rising depression populations and growing mental stress related issues are expected to drive the global Nootropic Products market over the forecast period as demand increases. However, high product prices, a strict regulatory framework and low product awareness could impede market growth over the forecast period. Global nootropic market provides a detailed outlook on nootropics across the globe with special emphasize on key regions such as North America, Europe, Asia Pacific, Central and South America and Middle East and Africa. The report on global nootropic market gives historical, current and future market size (US$ Mn) on the basis of application, distribution channel, and geography. This study analyses the global nootropic market dynamics in a detailed manner to identify current trends and drivers, growth opportunities and potential challenges to the key stakeholders in the operating market. In addition, PBI has analyzed the global market to better equip customers with possible investment opportunities across region and consumer unmet needs. Key stakeholders of the global assisted reproductive technology include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global assisted reproductive technology market.